Scientists have discovered a protein that plays a central role in promoting immunity to viruses and cancer, opening the door to new therapies.
Experiments in mice and human cells have shown that the protein promotes the proliferation of cytotoxic T cells, which kill cancer cells and cells infected with viruses. The discovery was unexpected because the new protein had no known function and doesn’t resemble any other protein.
Researchers from Imperial College London who led the study are now developing a gene therapy designed to boost the infection-fighting cells, and hope to begin human trials in three years.
The study also involved researchers at Queen Mary University of London, ETH Zurich and Harvard Medical School. Their discovery, which has been six years in the making, is reported today in the journal Science.
Cytotoxic T cells are an important component of the immune system, but when faced with serious infections or advanced cancer, they are often unable to proliferate in large enough quantities to fight the disease.
By screening mice with genetic mutations, the Imperial team discovered a strain of mice that produced 10 times as many cytotoxic T cells when infected with a virus compared with normal mice. These mice suppressed the infection more effectively, and were more resistant to cancer. They also produced more of a second type of T cells, memory cells, enabling them to recognise infections they have encountered previously and launch a rapid response.
The mice with enhanced immunity produced high levels of a hitherto unknown protein, which the researchers named lymphocyte expansion molecule, or LEM. They went on to show that LEM modulates the proliferation of human T cells as well as in mice.
The researchers now aim to develop a gene therapy designed to improve immunity by boosting the production of LEM. With the support of Imperial Innovations, the technology commercialisation company for the College, the researchers have filed two patents. A company called ImmunarT has been formed with the aim of commercialising the technology.
Professor Philip Ashton-Rickardt from the Section of Immunobiology in the Department of Medicine at Imperial, who led the study, said: “Cancer cells have ways to suppress T cell activity, helping them to escape the immune system. Genetically engineering T cells to augment their ability to fight cancer has been a goal for some time and techniques for modifying them already exist. By introducing an active version of the LEM gene into the T cells of cancer patients, we hope we can provide a robust treatment for patients.
“Next we will test the therapy in mice, make sure it is safe and see if it can be combined with other therapies. If all goes well, we hope to be ready to carry out human trials in about three years.”
The Latest on: Cytotoxic T cell
via Google News
The Latest on: Cytotoxic T cell
- Novel Strategy Reduces Lung and Liver Fibrosis in Miceon September 16, 2022 at 5:00 am
Vaccination-based immunotherapy to target fibroblasts of the cells of the lung and liver in mice may lead to effective treatment for fibrosis.
- University Of New South Wales: T cells use force to destroy cancer cellson September 15, 2022 at 11:37 pm
As a part of our immune defences, cytotoxic T cells – or killer T cells – seek out and destroy cells that are infected or cancerous.These specialised immune cells are armed with lytic granules contain ...
- T cells use force to destroy cancer cellson September 15, 2022 at 9:17 am
As a part of our immune defenses, cytotoxic T cells—or killer T cells—seek out and destroy cells that are infected or cancerous. This process is essential for the body's defense against diseases.
- Mechanical forces generated by T cells influence the destruction of cancer cellson September 15, 2022 at 9:02 am
As a part of our immune defenses, cytotoxic T cells – or killer T cells – seek out and destroy cells that are infected or cancerous. This process is essential for the body's defense against diseases.
- T cells use force to destroy cancer cellson September 15, 2022 at 8:00 am
As a part of our immune defences, cytotoxic T cells – or killer T cells – seek out and destroy cells that are infected or cancerous. This process is essential for the body’s defence against ...
- T cells use force to destroy cancer cellson September 14, 2022 at 5:00 pm
New research reveals the mechanical processes used by T cells to kill cancer cells more efficiently. As a part of our immune defences, cytotoxic T cells -- or killer T cells -- seek out and ...
- PDC*line Pharma Presents First Clinical Results From Phase I/II trial With PDC*lung01 at ESMO 2022on September 12, 2022 at 5:02 pm
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, today announces the first results of PDC-LUNG-101 phase I/II ...
- NR2F6 antagonist TES-4207 shows promising preclinical results for canceron September 8, 2022 at 5:00 pm
The interaction of immune checkpoints, such as programmed cell death protein 1 (PD-1) or cytotoxic T-lymphocyte antigen-4 (CTLA-4), with their ligands leads to T-cell deactivation, allowing cancer ...
via Bing News